Lan Shen

684 total citations · 1 hit paper
23 papers, 532 citations indexed

About

Lan Shen is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Lan Shen has authored 23 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Lan Shen's work include Peroxisome Proliferator-Activated Receptors (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Lan Shen is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Lan Shen collaborates with scholars based in United States and China. Lan Shen's co-authors include Jun Yan, P. Magnus, Gee‐Hong Kuo, Xiao‐Li Zhao, Zhong‐Yan Cao, Jian Zhou, Pengwei Xu, William V. Murray, Keith T. Demarest and Jun Xu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Lan Shen

22 papers receiving 518 citations

Hit Papers

Cancer-Associated Fibroblast–Derived miR-146a-5p Generate... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer-Associated Fibroblast–Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance
    2023 96 citations Junlong Zhuang, Lan Shen et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Shen United States 12 282 241 68 46 35 23 532
E. Hampton Sessions United States 16 240 0.9× 295 1.2× 117 1.7× 27 0.6× 32 0.9× 20 635
Paul A. Tuthill United States 9 149 0.5× 167 0.7× 66 1.0× 49 1.1× 54 1.5× 14 371
Gregory R. Luedtke United States 11 253 0.9× 158 0.7× 58 0.9× 28 0.6× 48 1.4× 15 425
Roberta Tesch Germany 14 217 0.8× 263 1.1× 76 1.1× 39 0.8× 32 0.9× 20 520
Fong‐Chi Cheng Taiwan 11 110 0.4× 231 1.0× 38 0.6× 34 0.7× 37 1.1× 19 414
Shaun R. Selness United States 10 114 0.4× 206 0.9× 54 0.8× 50 1.1× 23 0.7× 12 359
J. Adam Willardsen United States 13 479 1.7× 270 1.1× 78 1.1× 30 0.7× 34 1.0× 22 712
Sultan Nacak Baytaş Türkiye 17 477 1.7× 267 1.1× 51 0.8× 21 0.5× 84 2.4× 34 694
Malin Lemurell Sweden 12 184 0.7× 402 1.7× 49 0.7× 31 0.7× 60 1.7× 15 587
Stuart C. Wilson United Kingdom 10 208 0.7× 305 1.3× 147 2.2× 35 0.8× 19 0.5× 14 555

Countries citing papers authored by Lan Shen

Since Specialization
Citations

This map shows the geographic impact of Lan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Shen more than expected).

Fields of papers citing papers by Lan Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Shen. The network helps show where Lan Shen may publish in the future.

Co-authorship network of co-authors of Lan Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Shen. A scholar is included among the top collaborators of Lan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Shen. Lan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Jing, Lan Shen, Hunseung Kang, & Tao Xu. (2024). RNA modifications in plant adaptation to abiotic stresses. Plant Communications. 6(2). 101229–101229. 13 indexed citations
2.
Zhuang, Junlong, Lan Shen, Meiqian Li, et al.. (2023). Cancer-Associated Fibroblast–Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance. Cancer Research. 83(10). 1611–1627. 96 indexed citations breakdown →
3.
4.
Xu, Pengwei, Lan Shen, Zhong‐Yan Cao, et al.. (2017). Diastereo- and enantioselective [3 + 3] cycloaddition of spirocyclopropyl oxindoles using both aldonitrones and ketonitrones. Nature Communications. 8(1). 1619–1619. 96 indexed citations
5.
Rudin, Charles M., Lan Shen, & M. Catherine Pietanza. (2017). KEYNOTE-604: Phase 3 trial of pembrolizumab plus etoposide/platinum (EP) for first-line treatment of extensive stage small-cell lung cancer (ES-SCLC). Annals of Oncology. 28. v541–v541. 6 indexed citations
6.
Rudin, Charles M., Lan Shen, & M. Catherine Pietanza. (2017). P2.04-007 KEYNOTE-604: Phase 3 Randomized, Double-Blind Trial of Pembrolizumab/Placebo plus Etoposide/Platinum for Extensive Stage-SCLC. Journal of Thoracic Oncology. 12(11). S2400–S2400. 6 indexed citations
7.
Barreto, Andrew D., Gary A. Ford, Lan Shen, et al.. (2015). ARTSS-2: A pilot, phase IIb, randomised, multi-center trial of argatroban in combination with recombinant tissue plasminogen activator for acute stroke. International Journal of Stroke. 10. 420–420. 1 indexed citations
8.
Shen, Lan, Yan Zhang, Aihua Wang, et al.. (2007). Synthesis and structure–activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors α/δ dual agonists. Bioorganic & Medicinal Chemistry. 16(6). 3321–3341. 21 indexed citations
9.
Shen, Lan, Yan Zhang, Aihua Wang, et al.. (2007). Synthesis and Identification of [1,2,4]Thiadiazole Derivatives as a New Series of Potent and Orally Active Dual Agonists of Peroxisome Proliferator-Activated Receptors α and δ. Journal of Medicinal Chemistry. 50(16). 3954–3963. 34 indexed citations
10.
Bruera, Éduardo, Badi El Osta, Vicente Valero, et al.. (2007). Donepezil for cancer-related fatigue: A double-blind, randomized, placebo-controlled study. Journal of Clinical Oncology. 25(18_suppl). 9003–9003. 4 indexed citations
11.
O’Neill, David J., Lan Shen, Catherine Prouty, et al.. (2004). Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3β (GSK-3β) inhibitors. Bioorganic & Medicinal Chemistry. 12(12). 3167–3185. 41 indexed citations
12.
Shen, Lan, Catherine Prouty, Barbara R. Conway, et al.. (2004). Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3β (GSK-3β) inhibitors. Bioorganic & Medicinal Chemistry. 12(5). 1239–1255. 29 indexed citations
13.
Magnus, Philip, et al.. (2004). Some reactions of persistent benzofuranone radicals related to the ‘old’ diazonamide structure. Tetrahedron Letters. 46(4). 707–710. 17 indexed citations
14.
Kuo, Gee‐Hong, Catherine Prouty, Lan Shen, et al.. (2003). Synthesis and Discovery of Macrocyclic Polyoxygenated Bis-7-azaindolylmaleimides as a Novel Series of Potent and Highly Selective Glycogen Synthase Kinase-3β Inhibitors. Journal of Medicinal Chemistry. 46(19). 4021–4031. 72 indexed citations
15.
Lash, Timothy D., et al.. (2002). Metabolism of Analogues of Coproporphyrinogen-III with Modified Side Chains: Implications for Binding at the Active Site of Coproporphyrinogen Oxidase. Bioorganic & Medicinal Chemistry Letters. 12(3). 451–456. 4 indexed citations
16.
17.
18.
Magnus, P. & Lan Shen. (1999). Stereoselective synthesis of the “cyathin” diterpene skeleton via an intramolecular pyrylium ylide-alkene cyclization. Tetrahedron. 55(12). 3553–3560. 30 indexed citations
19.
Little, R. Daniel, et al.. (1978). Frontier orbital control of regiospecificity in singlet cycloadditions of 2-methylenecyclopenta-1,3-diyls. Tetrahedron Letters. 19(38). 3529–3532. 6 indexed citations
20.
Engel, Paul S., et al.. (1974). Thermolysis of peresters. Relative stability of allylic and propargylic radicals. The Journal of Organic Chemistry. 39(3). 384–388. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Hampton Sessions Breakdown of academic impact, for papers by Paul A. Tuthill Breakdown of academic impact, for papers by Gregory R. Luedtke Breakdown of academic impact, for papers by Roberta Tesch Breakdown of academic impact, for papers by Fong‐Chi Cheng Breakdown of academic impact, for papers by Shaun R. Selness Breakdown of academic impact, for papers by J. Adam Willardsen Breakdown of academic impact, for papers by Sultan Nacak Baytaş Breakdown of academic impact, for papers by Malin Lemurell Breakdown of academic impact, for papers by Stuart C. Wilson
Rankless by CCL
2026